Search Within

Neuroradiology Service

  1. "Meeting abstract"
  2. "Thoracic Oncology"
Formats
  1. Meeting Abstract (16)
Groups
  1. Department of Medicine (16)
  2. Radiology, Department of (16)
  3. Solid Tumor Oncology Division (16)
  4. Thoracic Oncology (16)
  5. GSK Faculty (9)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (8)

More Groups

People
  1. Mark Kris (9)
  2. Robert Young (7)
  3. Helena Yu (6)
  4. Adrienne Boire (4)
  5. Alexander Drilon (4)
  6. Andrei Holodny (4)

More People

Years
  1. 2023 (1)
  2. 2022 (4)
  3. 2020 (1)
  4. 2019 (1)
  5. 2018 (1)
  6. 2017 (1)

More Years

Publications
  1. Journal of Clinical Oncology (10)
  2. European Journal of Cancer (1)
  3. International Journal of Radiation Oncology, Biology, Physics (1)
  4. Journal of Thoracic Oncology (1)
  5. Neuro-Oncology (1)
  6. Neuro-Oncology Advances (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (10)
  2. Elsevier Inc. (3)
  3. Oxford University Press (2)
  4. Lippincott Williams & Wilkins (1)

Results (16)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase I study of paxalisib and radiotherapy for CNS disease harboring PI3K pathway mutations: Pilot analysis of circulating tumor DNA for patient eligibility confirmation and post-treatment response
    Meeting Abstract

    Imber, B.; Ravichandran, V.; Rao, P.; Casanova, H.; Friend, J.; Simpson, J.; Pike, L.; Zinovoy, M.; Mitchell, R.; Chacko, C.; more...
    Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • Phase II randomized study comparing proton craniospinal irradiation with photon involved-field radiotherapy for patients with solid tumor leptomeningeal metastasis
    Meeting Abstract

    Yang, J. T.; Wijetunga, N. A.; Pentsova, E.; Wolden, S. L.; Young, R. J.; Correa, D.; Zhang, Z.; Zheng, J.; Warner, A. B.; Yu, H. A.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • A phase Ia/Ib study of intrathecal deferoxamine in patients with leptomeningeal metastases
    Meeting Abstract

    Wilcox, J.; Modelevsky, L. R.; Thomas, T.; Cremers, S.; Young, R. J.; Reiner, A. S.; Panageas, K.; Yu, H. A.; Boire, A. A.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Phase II randomized trial comparing proton craniospinal irradiation with photon involved-field radiotherapy for patients with solid tumor leptomeningeal metastasis
    Meeting Abstract

    Yang, J. T.; Wijetunga, N. A.; Pentsova, E.; Wolden, S. L.; Young, R. J.; Correa, D.; Zhang, Z.; Zheng, J.; Betof Warner, A.; Yu, H.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Phase I study of concurrent paxalisib and radiation therapy in patients with solid tumor brain metastases or leptomeningeal metastases harboring PI3K pathway mutations: Results from the dose-escalation cohort
    Meeting Abstract

    Yang, J.; Mann, J.; Pike, L.; Zinovoy, M.; Young, R.; Offin, M.; Mitchell, R.; Kazarian, A.; Shadat, T.; Garner, J.; more...
    Neuro-Oncology Advances (2022)

    Fulltext@MSK | Save
  • A phase I/Ib study of lenvatinib and cetuximab in patients with recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC)
    Meeting Abstract

    Dunn, L.; Ho, A. L.; Eng, J.; Michel, L. S.; Fetten, J. V.; Warner, E.; Kriplani, A.; Zhi, W. I.; Ng, K. K.; Haque, S.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • A phase 1/2 study of osimertinib and bevacizumab as initial treatment for patients with metastatic EGFR-mutant lung cancers
    Meeting Abstract

    Yu, H. A.; Kim, R.; Makhnin, A.; Ahn, L. S. H.; Ni, A.; Hayes, S. A.; Young, R. J.; Riely, G. J.; Kris, M. G.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Frequency of brain metastases and outcomes in patients with HER2-, KRAS-, and EGFR-mutant lung cancers
    Meeting Abstract

    Kris, M. G.; Offin, M. D.; Feldman, D. L.; Ni, A.; Lai, W. C. V.; Arbour, K. C.; Daras, M.; Pentsova, E.; DeAngelis, L. M.; Beal, K.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Baseline frequency of brain metastases and outcomes with multikinase inhibitor therapy in patients with RET-rearranged lung cancers
    Meeting Abstract

    Drilon, A. E.; Filleron, T.; Bergagnini, I.; Milia, J.; Hatzoglou, V.; Velcheti, V.; Besse, B.; Mok, T.; Awad, M. M.; Wolf, J.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Overcoming drug resistance to Trk inhibition by rational combination of entrectinib and trametinib: From bench to bedside
    Meeting Abstract

    Ho, A.; Wei, G.; Maneval, E. C.; Esquibel, V.; Berger, M. F.; Haque, S.; Patel, R.; Walsh, C.; Hornby, Z.; Multani, P.; more...
    European Journal of Cancer (2016)

    Fulltext@MSK | Save